APA (7th ed.) Citation

Katakami, N., Mita, T., Yoshii, H., Shiraiwa, T., Yasuda, T., Okada, Y., . . . Shimomura, I. (2020). Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: A prospective, randomized, open-label, parallel-group comparative study. Cardiovascular diabetology, 19(1), 110-16. https://doi.org/10.1186/s12933-020-01079-4

Chicago Style (17th ed.) Citation

Katakami, Naoto, et al. "Tofogliflozin Does Not Delay Progression of Carotid Atherosclerosis in Patients with Type 2 Diabetes: A Prospective, Randomized, Open-label, Parallel-group Comparative Study." Cardiovascular Diabetology 19, no. 1 (2020): 110-16. https://doi.org/10.1186/s12933-020-01079-4.

MLA (9th ed.) Citation

Katakami, Naoto, et al. "Tofogliflozin Does Not Delay Progression of Carotid Atherosclerosis in Patients with Type 2 Diabetes: A Prospective, Randomized, Open-label, Parallel-group Comparative Study." Cardiovascular Diabetology, vol. 19, no. 1, 2020, pp. 110-16, https://doi.org/10.1186/s12933-020-01079-4.